Godsey & Gibb Inc’s Molecular Templates, Inc. MTEM Stock Holding History

Godsey & Gibb Inc’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7	Closed	–	–	343
2022 Q3	$0	Buy	+7	New	+$88	﹤0.01%	172

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Godsey & Gibb Inc's MTEM Position: Q4 2022 in Review

Godsey & Gibb Inc sold out of Molecular Templates, Inc. (MTEM) in Q4 2022, closing a stake of 7 shares.

Godsey & Gibb Inc first reported a position in MTEM in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 50 funds tracked by Wall St. Rank hold MTEM as of Q4 2022.

Godsey & Gibb Inc reported no remaining Molecular Templates, Inc. position as of Q4 2022 after selling out during the quarter.
Godsey & Gibb Inc sold 7 Molecular Templates, Inc. shares in Q4 2022.
Godsey & Gibb Inc first reported a position in Molecular Templates, Inc. in Q3 2022 and held it in 1 quarter.
Godsey & Gibb Inc's Molecular Templates, Inc. position peaked at $0 in Q3 2022.
50 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2022.

Based on Godsey & Gibb Inc's 13F filing for Q4 2022, filed 18 Jan 2023.